Merck KGaA Signs Versum Buyout Deal; Entegris Receives Termination Payment


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Versum Materials (NYSE:VSM) has approved a "superior" buyout proposal from MERCK KGAA/S ADR (OTC:MKKGY) at $53 per share after backing out of a previously announced merger with Entegris Inc (NASDAQ:ENTG).

What Happened

ENTER TO WIN $500 IN STOCK OR CRYPTO

Enter your email and you'll also get Benzinga's ultimate morning update AND a free $30 gift card and more!

The business combination received unanimous approval from the boards of the German pharmaceutical company and Versum, Merck said in a Friday press release.

The deal is expected to be immediately accretive to Merck's earnings per share and to generate 75 million euros ($84.9 million) in run-rate synergies by the third full year after closing, Merck said. 

Versum is a supplier of process chemicals, gases and semiconductor manufacturing equipment. Merck said the tie-up is projected to bolster its performance materials segment and create a leading electronic materials business targeting the semiconductor and display industries. 

Versum's Tempe, Arizona headquarters will be maintained as the major hub for the combined electronic materials business, Merck said.

Entegris said in a separate statement Friday that it has received a $140-million termination fee payment from Versum. 

Why It’s Important

The price of the Versum buyout reflects an enterprise value of about 5.8 billion euros for the company and implies an EV/2019 EBITDA multiple of approximately 13.7x, according to Friday's announcement. 


FREE REPORT: How To Learn Options Trading Fast

In this special report, you will learn the four best strategies for trading options, how to stay safe as a complete beginner, ​a 411% trade case study, PLUS how to access two new potential winning options trades starting today.Claim Your Free Report Here.


Merck said it's financing the transaction with cash and debt. 

Versum Chairman Seifi Ghasemi said the deal gives shareholders "compelling and certain value" and holds long-term benefits for customers and employees. 

"This exciting business combination will create increased scale, product and service depth, enhanced global presence, strengthened supply chain and combined R&D capabilities, driving leading innovation. We look forward to joining together our respective businesses and talented teams."

What's Next 

The buyout is projected to close in the second half of this year and is subject to Versum shareholder approval, as well as regulatory clearance and other customary closing provisions, Merck said. 

Over-the-counter Merck shares were falling by 1.95 percent to $21.93 at the time of publication Friday. Versum shares were trading up slightly at $51.95. Entegris shares were jumping by 2.79 percent to $40.37. 

Related Links: 

Versum Materials Says Revised Merck KGaA Buyout Proposal 'Superior' To Entegris Offer

With Semiconductor Demand Uncertain, KeyBanc Presents Stock Ideas 

Photo by Merck via Wikimedia


Crypto Whales Are Loading Up — Are You?

New research shows the biggest crypto buyers are back. And this time? They could hold for the possibility that Bitcoin will surpass $100,000 in 2024. You don’t want to miss the next massive crypto bull run like we saw in 2020 and 2021. To know exactly what’s going on and what to buy… Get Access To Benzinga’s Best Crypto Research and Investments For Only $1.


Posted In: NewsEurozoneM&AMarketspharmasemiconductors